UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 400

Sortiert nach

Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates

Science (American Association for the Advancement of Science), 1993-07, Vol.261 (5118), p.212-215

1993

Volltextzugriff (PDF)

(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin

Bioconjugate chemistry, 1993-11, Vol.4 (6), p.521-527

1993

Volltextzugriff (PDF)

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates

Cancer research (Chicago, Ill.), 1997, Vol.57 (1), p.100-105

1997

Volltextzugriff (PDF)

Synthesis and antitumor activity of the immunoconjugate BR96-Dox

Journal of controlled release, 1996-05, Vol.39 (2), p.251-259

1996

Volltextzugriff (PDF)

Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers: A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates

Bioconjugate chemistry, 1999-03, Vol.10 (2), p.279-288

1999

Volltextzugriff (PDF)

Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models

Cancer research (Chicago, Ill.), 1992-10, Vol.52 (20), p.5693-5700

1992

Volltextzugriff (PDF)

Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity

Bioconjugate chemistry, 2002-07, Vol.13 (4), p.855-869

2002

Volltextzugriff (PDF)

Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains

Journal of medicinal chemistry, 2002-09, Vol.45 (19), p.4336-4343

2002

Volltextzugriff (PDF)

Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages

Bioorganic & medicinal chemistry letters, 2002-06, Vol.12 (11), p.1529-1532

2002

Volltextzugriff (PDF)

BR96 conjugates of highly potent anthracyclines

Bioorganic & medicinal chemistry letters, 2003-07, Vol.13 (13), p.2119-2122

2003

Volltextzugriff (PDF)

Using Fourier transform IR spectroscopy to analyze biological materials

Nature protocols, 2014-08, Vol.9 (8), p.1771-1791

2014

Volltextzugriff (PDF)

Climate change and European forests: What do we know, what are the uncertainties, and what are the implications for forest management?

Journal of environmental management, 2014-12, Vol.146, p.69-83

2014

Volltextzugriff (PDF)

Logistics Management: Contributions of the Section Logistics of the German Academic Association for Business Research, 2023, Dresden, Germany

1, 2023

Volltextzugriff (PDF)

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Inflammatory bowel diseases, 2017-01, Vol.23 (1), p.97-106

2017

Volltextzugriff (PDF)

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation

Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (1), p.83-92

2014

Volltextzugriff (PDF)

Accuracy, realism and general applicability of European forest models

Global change biology, 2022-12, Vol.28 (23), p.6921-6943

2022

Volltextzugriff (PDF)

Logistics Management: Contributions of the Section Logistics of the German Academic Association for Business Research, 2021, Dresden, Germany

1st Edition 2021, 2021

Volltextzugriff (PDF)

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

PloS one, 2017-05, Vol.12 (5), p.e0175674-e0175674

2017

Volltextzugriff (PDF)

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

PloS one, 2018-08, Vol.13 (8), p.e0201964-e0201964

2018

Volltextzugriff (PDF)

Luminous Type II supernovae for their low expansion velocities

Monthly notices of the Royal Astronomical Society, 2020-06, Vol.494 (4), p.5882-5901

2020

Volltextzugriff (PDF)

Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (2), p.264-275

2017

Volltextzugriff (PDF)

Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO

Quality of life research, 2015-03, Vol.24 (3), p.769-780

2015

Volltextzugriff (PDF)

Development of a method for shredder characterisation and dynamic control of the output material stream

Journal of sustainable development of energy, water and environment systems, 2024-09, Vol.12 (3), p.1-10

2024

Volltextzugriff (PDF)

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Clinical gastroenterology and hepatology, 2022-01, Vol.20 (1), p.126-135

2022

Volltextzugriff (PDF)

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

The American journal of gastroenterology, 2018-09, Vol.113 (9), p.1345

2018

Volltextzugriff (PDF)

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(318)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(363)
Japanisch
(28)
Deutsch
(22)
Französisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(205)
Life Sciences & Biomedicine
(149)
Humans
(105)
Biological And Medical Sciences
(56)
Biochemistry & Molecular Biology
(55)
Chemistry
(54)
Physical Sciences
(52)
Female
(46)
Male
(44)
Animals
(43)
Medical Sciences
(35)
Adult
(32)
Middle Aged
(28)
Social Sciences
(28)
Technology
(26)
Fundamental And Applied Biological Sciences. Psychology
(22)
Kinetics
(22)
Exact Sciences And Technology
(21)
Management
(21)
Chemistry, Multidisciplinary
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates

(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates

Synthesis and antitumor activity of the immunoconjugate BR96-Dox

Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers: A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates

Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models

Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity

Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains

Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages

BR96 conjugates of highly potent anthracyclines

Using Fourier transform IR spectroscopy to analyze biological materials

Climate change and European forests: What do we know, what are the uncertainties, and what are the implications for forest management?

Logistics Management: Contributions of the Section Logistics of the German Academic Association for Business Research, 2023, Dresden, Germany

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation

Accuracy, realism and general applicability of European forest models

Logistics Management: Contributions of the Section Logistics of the German Academic Association for Business Research, 2021, Dresden, Germany

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

Luminous Type II supernovae for their low expansion velocities

Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial

Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO

Development of a method for shredder characterisation and dynamic control of the output material stream

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Suchergebnisse filtern